Skip to main content

Advertisement

SpringerLink
Log in

Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma

  • Reply
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Fallanca F, Alongi P, Incerti E, Gianolli L, Picchio M, Kayani I, et al. Diagnostic accuracy of FDG PET/CT for clinical evaluation at the end of treatment of HL and NHL: a comparison of the Deauville Criteria (DC) and the International Harmonization Project Criteria (IHPC). Eur J Nucl Med Mol Imaging. 2016;43:1837–48.

  2. Adams HJ, Kwee TC. Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score? Br J Haematol. 2016. doi:10.1111/bjh.14052.

  3. Adams HJ, Nievelstein RA, Kwee TC. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol. 2015;170:185–191.

    Article  CAS  Google Scholar 

  4. Metser U, Mohan R, Beckley V, Moshonov H, Hodgson D, Murphy G. FDG PET/CT response assessment criteria for patients with Hodgkin’s and non-Hodgkin’s lymphoma at end of therapy: a multiparametric approach. Nucl Med Mol Imaging. 2016;50:46–53.

    Article  CAS  Google Scholar 

  5. Zhou Z, Sehn LH, Rademaker AW, Gordon LI, Lacasce AS, Crosby-Thompson A, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood. 2014;123:837–842.

  6. Hasenclever D, Diehl V. A prognostic score for advanced Hodgkin’s disease. International Prognostic Factors Project on Advanced Hodgkin’s Disease. N Engl J Med. 1998;339:1506–1514.

    Article  CAS  Google Scholar 

  7. Solal-Céligny P, Roy P, Colombat P, White J, Armitage JO, Arranz-Saez R, et al. Follicular Lymphoma International Prognostic Index. Blood. 2004;104:1258–1265. 

Download references

Author information

Authors and Affiliations

  1. Unit of Nuclear Medicine, IRCCS San Raffaele Scientific Institute, Milan, Italy

    Federico Fallanca, Pierpaolo Alongi, Elena Incerti, Luigi Gianolli & Maria Picchio

  2. Nuclear Medicine Unit, Department of Radiological Sciences, San Raffaele G. Giglio Institute, Cefalù, Italy

    Pierpaolo Alongi

  3. University College London Hospital, London, UK

    Irfan Kayani & Jamshed B. Bomanji

  4. Department of Nuclear Medicine, University College Hospitals NHS Foundation Trust, 235 Euston Rd, London, NW1 2BU, UK

    Jamshed B. Bomanji

Authors
  1. Federico Fallanca
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierpaolo Alongi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Incerti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Luigi Gianolli
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Maria Picchio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Irfan Kayani
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jamshed B. Bomanji
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jamshed B. Bomanji.

Additional information

This reply refers to the letter to the editor at doi:10.1007/s00259-016-3553-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fallanca, F., Alongi, P., Incerti, E. et al. Reply to letter of Adams and Kwee: Critical considerations on the predictive value of end-of-treatment FDG/PET in lymphoma. Eur J Nucl Med Mol Imaging 44, 344–345 (2017). https://doi.org/10.1007/s00259-016-3554-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-016-3554-7

Search

Navigation